Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment

Hepato-Gastroenterology

Volumn 45, Issue 21, 1998, Pages 742-751

  Annibale, Bruno ^a,e   Franceschi, Massimo ^b   Fusillo, Michele ^c,d   Beni, Massimo ^c   Cesana, Bruno ^d   Fave, Gianfranco Delle ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Schering Plough   (Italy)

^c IRCCS Ospedale Maggiore Milano ^*

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e POLICLINICO UMBERTO I   (Italy)

Author keywords

Maintenance therapy; Omeprazole; Ranitidine; Reflux esophagitis

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPIGASTRIC PAIN; ERYTHEMA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEADACHE; HEALING; HUMAN; LIBIDO; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REFLUX ESOPHAGITIS; RELAPSE; REMISSION; TIME;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; EVALUATION STUDIES; HUMANS; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; RANITIDINE; RECURRENCE; TREATMENT OUTCOME;

EID: 0031873984     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Sandmark S, Carlsson R, Fausa O, Lundell I. Omeprazole or ranitidine in the treatment of reflux esophagitis: results of a double blind randomised multicentre study. Scand J Gastroenterol 1988; 23:625-632.
2. Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA. Omeprazole and ranitidine in the treatment of reflux esophagitis: double blind comparative trial. Br Med J 1988; 296:89-92.
3. Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts JL. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33:523-529.
4. Kiinkenberg-Knoi EC, Jansen JMBJ, Festen HPM, Meuwissen SGM, Lamers CBHW. Double blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1987; 1:349-351.
5. Lundell L, Backman L, Ekstrom P, et al. Omeprazole or high dose ranitidine in the treatment of patients with reflux esophagitis not responding to standard doses of H2 receptor antagonists. Aliment Pharmacol Ther 1990; 4:145-155.
6. Tytgat GNJ, Nio CY, Schotborgh RH. Reflux esophagitis. Scand J Gastroenterol 1990; 25(Suppl 175):1-12.
7. Dehn TCB, Shepherd HA, Colin-Jones D, Kettieweli MGW, Carroli NJH. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux esophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut 1990; 31:509-513.
8. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe reflux esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-912.
9. Wienbeck M, Barnet J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 24(Suppl.156):7-13.
10. Bardhan KD, Daly MI, Singh S, Morris P, Thompson M, Hinchliffe RFC. Refractory esophagitis: results of maintenance treatment with high-dose H2 receptor antagonists H2RA or omeprazole (abstr). Gastroenterology 1990; 98:A18.
11. Lundell L, Backman L, Ekstrom P, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991; 26:248-256.
12. Hallerback B, Unge P, Carling L, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994; 107:1305-1311.
13. Dent J.Yeomans ND, Mackinnon M, et al. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double trial of their efficacy and safety. Gut 1994; 35:590-598.
14. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36:492-498.
15. Wienbeck M, Barnett J. Epidemiology of reflux disease and reflux esophagitis. Scand J roenterol 1989; 24(Suppl.156):7,18.
16. Kaplan EL, Meir P. Non parametric estimation from incomplete observations. J Amer Statist Assoc 1958; 53:457-481.
17. Mantel N, Haenszel W. Statistical aspect of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748.
18. Cox DR. Regression models on life tables. J Royal Stat Soc 1972; 34:187-220.
19. Dent J, Kiinkenberg-Knoi E, Elm G, Eriksson K, Rikner L, Solvell L.Omeprazole in the long term management of patients with reflux esophagitis refractory to histamine H2-receptor antagonists. Gastroenterol Int 1988; 1(Suppl 1):A847.
20. Kiinkenberg-Knoi EC, Jansen JBMJ, deBruyne JW, et al. Long-term efficacy and safety of omeprazole on healing and prevention of resistant reflux esophagitis. Gastroenterology 1988; 94:A230.
21. Laursen LS, Bondesen S, Hansen J, et al. Omeprazole 10 mg or 20 mg daily for the prevention of relapse in gastroesophageal reflux disease? A double-blind comparative study (abstr). Gastroenterology 1992; 102:A109.
22. Sontag S, Robinson M, Roufail W, et al. Daily omeprazole is needed to maintain healing in erosive esophagitis: a multicenter double-blind study. Am J Gastroenterol 1992; 87:A1258.
23. Vigneri S,Termini R,Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Eng J Med 1995; 333:1106-10.
24. Antonson CW, Robinson MG, Hawkins TM, Mcintosh DL, Campbell DR. High doses of histamine antagonists do not prevent relapses of peptic esophagitis following therapy with a proton pump inhibitor. Gastroenterology 1990; 98:A16.
25. Janish HD, Hiittemann W, Bouzo MH. Cisapride versus ranitidine inthe treatment of reflux eosophagitis. Hepatogastroenterology 1988; 35:125-7
26. Geldof H, Hazelhoff B, Otten MH. Two different dose regimens of cisapride in the treament of reflux oesophagitis: a double-blind comparison with ranitidine. Alim Pharm Ther 1993; 7:409-415.
27. Koelz HR, Birchier A, Brethojz, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91:1198-1205.
28. Kliinkenberg-Knoi EC. The role of omeprazole in healing and prevention of reflux disease. Hepatogastroenterology 1992; 39(Suppl 1):27-30.
29. Hetzel DJ, Carisson R, Dent J, Lundell L. Relapse of esophagitis after endoscopic heaiing: an analysis of unfavourable prognostic factors. Scand J Gastroenterol 1989; 24(Suppl.166):A175.